초록 ▼

A process is provided for enhancing reproductive performance in a companion animal such as a dog or cat by feeding the animal a diet including omega-6 and omega-3 fatty acids in a ratio of from about 3.5:1 to about 12.5:1. When an animal is fed the diet of the present invention, the essential fatty

A process is provided for enhancing reproductive performance in a companion animal such as a dog or cat by feeding the animal a diet including omega-6 and omega-3 fatty acids in a ratio of from about 3.5:1 to about 12.5:1. When an animal is fed the diet of the present invention, the essential fatty acid status in the animal is maintained, and litter size is maintained through subsequent parities.

대표청구항 ▼

A process is provided for enhancing reproductive performance in a companion animal such as a dog or cat by feeding the animal a diet including omega-6 and omega-3 fatty acids in a ratio of from about 3.5:1 to about 12.5:1. When an animal is fed the diet of the present invention, the essential fatty

A process is provided for enhancing reproductive performance in a companion animal such as a dog or cat by feeding the animal a diet including omega-6 and omega-3 fatty acids in a ratio of from about 3.5:1 to about 12.5:1. When an animal is fed the diet of the present invention, the essential fatty acid status in the animal is maintained, and litter size is maintained through subsequent parities. sion of desired cells bound to fibrin microbeads, (ii) applying the suspension to the surface of a prosthetic device; and (iii) culturing the cells in a tissue culture medium under conditions permitting the formation of tissue on the surface of the prosthetic device, wherein the fibrin microbeads are prepared in the absence of glutaraldehyde as a cross-linking agent, and wherein the fibrin microbeads are prepared by a method comprising the sequential steps of: (i) preparing an aqueous solution comprising fibrinogen, thrombin and Factor XIII; (ii) prior to the onset of coagulation, contacting said aqueous solution with an oil heated to a temperature of about 50-80° C. to form an emulsion; (iii) mixing the emulsion at a temperature of about 50-80° C. until fibrin microbeads comprising extensively cross-linked fibrin(ogen) are obtained; and (iv) isolating the fibrin microbeads. 10. The method of claim 9, wherein the cells are selected from the group consisting of fibroblasts, endothelial cells, chondrocytes, neuroblastoma cells, kidney cells, liver cells, pancreatic cells, thyroid cells, glial cells, smooth muscle cells, bone/cartilage forming cells, and any combination thereof.11. The method of claim 9, wherein the suspension is applied to the surface of the prosthetic device by fibrin glue.